By participant health status: five studies on obese older adults (59–63) reported a significant TNF-α reduction (MD = −1.81 pg/mL, 95% CI: −3.65 to 0.02), while no significant effects were observed in older adults with diabetes mellitus, MetS, or healthy populations. This evidence concerns the gene TNF and metabolic syndrome.